Abstract. Choline is essential for synthesis of the major membrane phospholipid phosphatidylcholine. Moreover, it serves as a precursor for synthesis of the neurotransmitter acetylcholine (ACh). Keratinocytes of the epidermis synthesize and release ACh. The uptake of choline is the rate-limiting step in both ACh synthesis and choline phospholipid metabolism, and it is a prerequisite for keratinocyte proliferation. However, the nature of the choline transport system in keratinocytes is poorly understood. In this study, we examined the molecular and functional characterization of choline uptake into cultured human keratinocytes. Choline uptake into keratinocytes was independent of extracellular Na + , saturable, and mediated by a single transport system with an apparent Michaelis-Menten constant of 12.3 μM. Choline uptake was reduced when the keratinocyte membrane potential was depolarized by high K + . These results provide evidence that the choline transport activity is potential-sensitive. Various organic cations inhibit the choline transport system. RT-PCR demonstrated that keratinocytes expressed mRNA for choline transporter-like protein 1 (CTL1), mainly the CTL1a subtype. The present biochemical and pharmacological data suggest that CTL1a is functionally expressed in human keratinocytes and is responsible for the uptake of choline and organic cations in these cells.
Introduction
Human epidermal keratinocytes synthesize, secrete, and degrade acetylcholine (ACh) and use their cellsurface nicotinic and muscarinic cholinergic receptors to mediate the autocrine and paracrine system of ACh. Endogenous ACh regulates keratinocyte functions such as cell proliferation, differentiation, migration, and adhesion (1 -3) . Thus, non-neuronal cholinergic systems are expressed in human keratinocytes and are involved in the regulation of their function, and cholinergic dysfunction is related to the pathophysiology of certain diseases such as atopic dermatitis and psoriasis (3) . Choline acts as a precursor for synthesis of the neurotransmitter ACh. It is a precursor of phosphatidylcholine and sphingomyelin, which act as components of biological membranes and precursors for intracellular messengers such as diacylglycerol or ceramide. Interestingly, choline is required by human epidermal keratinocytes for optimal proliferation and differentiation. This choline requirement is specific for keratinocytes since dermal fibroblasts and epidermal melanocytes were not affected by choline supplementation (4) . Thus, intracellular choline accumulation through choline transporters is the rate-limiting step in ACh synthesis and choline phospholipid metabolism, and it is a prerequisite for keratinocyte proliferation. However, the uptake system of choline and the functional expression of choline transporters in human keratinocytes are poorly understood.
The choline transport system has been categorized into three transporter families according to their affinity for choline. A high-affinity choline transporter (CHT1) has recently been cloned and characterized and is thought to play an important role in cholinergic neurons (5, 6) . CHT1 is a Cl − -and Na that is highly sensitive to the choline analogue HC-3, and it is thought to be part of the rate-limiting step in ACh synthesis. CHT1 is also expressed by subpopulations of non-neuronal cholinergic cells such as ciliated cells of the airway epithelium (7, 8) and keratinocytes (9) . However, functional studies have shown that the airway epithelial cell line A549 expresses both a Na + -dependent CHT1 and a lower-affinity Na + -independent choline transporter (10) . As an organic cation, choline is known to be a substrate for carriers of organic cation transporters (OCTs). To date, three different OCTs (OCT1-3) have been cloned and their function, which involves a Na + -independent uptake mechanism, has been characterized (11) . These transporters recognize a multitude of endogenous and exogenous organic cations as substrates and exhibit considerable overlap in substrate specificity. Choline also interacts with these transporters with varying affinity. OCT1 and OCT2 accept choline as a substrate with comparatively low affinity. However, OCT3 does not recognize choline as a substrate (12 -14) . Recently, a distinct choline transporter called choline transporter-like (CTL) protein has been demonstrated in various human tissues (15) . CTL1 has been cloned from Torpedo marmorata and was first cloned as a suppressor for a yeast choline transport mutation from a Torpedo electric lobe yeast expression library by functional complementation (15) . Functional characterization studies with CTL1 in rats have shown that CTL1 is a Na + -independent, intermediate-affinity transporter of choline that can be completely inhibited by a high concentration of HC-3 (16, 17) .
This study was performed to functionally characterize choline uptake and sought to identify the transporters that mediate choline uptake in human keratinocytes. 3 H]choline was kept constant at 10 nM and unlabeled choline was added to give the desired choline concentrations. The nonspecific component of uptake was determined from the radioactivity associated with the cells when incubation was performed with [
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3 H]choline in the presence of 30 mM unlabeled choline. Total uptake at each concentration of choline was adjusted for this nonspecific uptake to calculate the saturable component. Data were analyzed by nonlinear regression and confirmed by linear regression. K i values were derived from IC 50 values as described by Cheng and Prusoff (18) . Inhibition data were plotted to a sigmoid curve with a variable slope and used to determine 50% inhibitory concentrations (IC 50 s). K i values were then obtained using the ChengPrusoff equation,
, where L is the concentration of radiolabeled ligand. Protein concentrations were determined using a DC Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA, USA).
RNA extraction and reverse transcription-polymerase chain reaction (RT-PCR)
Cells were washed with sterile Dulbecco's phosphatebuffered saline (D-PBS) and RNA was extracted by the acid guanidinium thiocyanate-phenol-chloroform method. Briefly, cells were lysed in ISOGEN and stored for 5 min at room temperature. Following the addition of chloroform and vortex mixing, the solution was centrifuged at 12,000 × g for 15 min at 4°C. The supernatant was collected, an equal volume of isopropanol was added, and the mixture was stored for 10 min at room temperature. The solution was centrifuged at 12,000 × g for 10 min at 4°C. The supernatant was removed, and RNA was precipitated by the addition of 70% ethanol and pelleted by centrifugation at 12,000 × g for 5 min at 4°C. Following a wash in 70% ethanol, the RNA pellet was air-dried and dissolved in RNase-and DNase-free water, and the optical density at 260 nm was measured to determine the amount of RNA.
Total RNA was reverse-transcribed into cDNA using a High Capacity cDNA Reverse Transcription kit according to the manufacturer's instructions. The pairs of primers and the TaqMan probes for the target mRNAs (CHT1, OCT1-3, CTL1, and housekeeping gene GAPDH) were designed based on the human mRNA sequence using TaqMan ® Gene Expression Assays (Applied Biosystems, Assay ID: CHT1, Hs00222367_m1; OCT1, Hs00427554_m1; OCT2, Hs01010723_m1; OCT3, Hs01009568_m1; CTL1, Hs00939357_m1; GAPDH, Hs99999905_m1). A master mix of TaqMan reagents was prepared and 10 ng of each RT sample was used in the TaqMan PCR reaction. For real-time PCR, TaqMan ® Fast Universal PCR Master Mix containing forward-, reverse-primer-, and TaqMan probe was used at 20 μl / tube, and the reaction was performed using the Applied Biosystems StepOne Plus TM Real-Time PCR System. The relative mRNA expression levels of the target genes in human keratinocytes were calculated using the comparative cycle time (Ct) method. The threshold Ct is the fractional PCR cycle number at which the fluorescent signal reaches the detection threshold. The target PCR Ct value is normalized to the GAPDH PCR Ct value by subtracting the GAPDH Ct value from the target PCR Ct value, which gives the ΔCt value. From this ΔCt value, the relative mRNA expression level to GAPDH for each target PCR can be calculated using the following equation: relative mRNA expression = 2 −(Ct target − Ct GAPDH) × 100 (%). The sequences of the specific primers for human CHT1, CTL1a, CTL1b, CTL1c, and GAPDH are summarized in Table 1 . The PCR reaction was performed using a TaKaRa PCR Thermal Cycler MP (Model TP3000; TaKaRa Biomedicals, Tokyo). For RT-PCR amplification, 0.5 μg total RNA was added to a 50 μl master mixture containing 1 × reaction buffer, 1.6 mM MgSO 4 , 1 × enzyme mixture, and 200 nM primers by using the SuperScript TM III One-Step RT-PCR System with Platinum ® Taq. PCR thermocycling consisted of an RT step at 55°C for 30 min and hot-start activation at 94°C for 2 min, followed by 30 amplification cycles of 94°C for 15 s, 60°C for 30 s, and 68°C for 1 min, with a final extension cycle at 68°C for 5 min. The PCR products were loaded on a 2% NuSieve agarose gel that had been pre-stained with 0.5 μg / ml ethidium bromide for electrophoresis in parallel with an appropriate DNA size marker. PCR products were visualized by UV illumination using Chemi Doc (BioRad Laboratories). 
Results
Time-course and kinetics of [ 3 H]choline uptake in human keratinocytes
We first examined the time-course of [ 3 H]choline uptake at a concentration of 10 nM in the presence and absence of Na + in keratinocytes for 60 min (Fig. 1a) . [
3 H]Choline uptake in keratinocytes increased in a timedependent manner; it was linear with time at up to 30 min. Based on these findings, subsequent experiments were performed using an uptake period of 10 min. When NaCl in the uptake buffer was replaced by NMDG, the uptake of [ 
Effects of various compounds on [
3
H]choline uptake in human keratinocytes
An inhibition study was performed to determine the substrate-selectivity of the choline transport system in keratinocytes (Fig. 2). [
3 H]Choline uptake was concentration-dependently inhibited by ACh, unlabeled choline, and HC-3 (Fig. 2a) Fig. 2b . Various organic cations, such as quinine, quinidine, desipramine, diphenhydramine, and clonidine, markedly inhibited [
3 H]choline uptake. The prototypical organic cation TEA and PAH, which is an organic anion that is transported by organic anion transporters, did not cause any significant inhibition at up to 1 mM. However, other n-tetraalkylammonium compounds, such as TBA and THA, inhibited [ 3 H]choline uptake. In addition, the selective inhibitors of L-and A-type amino acid transporters BHC (1 mM) and MeAIB (1 mM), the selective organic anion transport inhibitor DIDS (1 mM), and the vesicular monoamine transporter inhibitor vesamicol (10 μM) did not affect [ 
Influence of membrane depolarization on [
3
H]choline uptake in human keratinocytes
We investigated the electrogenicity of choline transport by examining the influence of membrane potential on [
3 H]choline uptake in keratinocytes (Fig. 3) . The membrane potential was depolarized by increasing the concentration of K + in the uptake buffer from 6 to 106 mM. [ 3 H]Choline uptake was significantly reduced when the keratinocyte cell membrane potential was depolarized by high K + . Expression of mRNA for CHT1, OCT1-3, and CTL1 and it splice variants, CTL1a, CTL1b, and CTL1c, in human keratinocytes The expression of mRNA for CHT1, OCT1-3, and CTL1 in keratinocytes was investigated by real-time PCR analysis (Fig. 4a) . CTL1 mRNA was mainly expressed and OCT1-3 mRNAs were expressed at low levels. However, under similar conditions, the expression of CHT1 mRNA was not detectable in keratinocytes.
We investigated the expression of CTL1 splice variants in keratinocytes (Fig. 4b) . Expression of CTL1a, CTL1b, and CTL1c mRNA was investigated by RT-PCR in RNA samples extracted from human keratinocytes. CTL1 and CTL1a mRNAs were expressed abundantly, and while CTL1b and CTL1c mRNAs were expressed at low levels, they were still detectable.
Discussion
It has been well established that human keratinocytes express receptors for ACh and that stimulation of these receptors promotes cell proliferation, differentiation, migration, and adhesion (3). Furthermore, keratinocytes can synthesize, secrete, and degrade ACh and this released ACh stimulates cell growth. Keratinocyte ACh acts in the epidermis as a local hormone (1). Choline is an essential nutrient for all cells because it plays a role in the synthesis of the membrane phospholipid components of cell membranes, as precursors for ceramide and ACh. The amount of ceramide is markedly reduced in the stratum corneum in lesional and non-lesional forearm skin of patients with atopic dermatitis (AD) (19) . However, tissue levels of ACh are greatly (14-fold) enhanced in superficial skin in AD (20) . Abnormal choline metabolism has been implicated in several cases of AD. Therefore, the study of choline transport and the characteristics of choline transporters are important for understanding the mechanisms that underlie membrane integrity and cell function in such disorders.
In this study, we found that human keratinocytes take 
up [
3 H]choline by a saturable process that is mediated by a single transport system. The K m value was 12.3 μM, which is similar to the blood concentration of choline (10 -25 μM). The kinetic parameters are very close to those of the choline transport system in endothelial cells of the blood-brain barrier (21), HaCaT cells (22) , and astrocytes (16); and these reports have shown conclusively that choline is taken up into these cells by a specific transporter that is not OCT1-3 or CHT1. In astrocytes, the inhibition of CTL1 mRNA expression using siRNA inhibited Na + -independent choline uptake, suggesting that CTL1 is responsible for Na + -independent choline uptake in these cells. The K m value for CTL1 was approximately 30 μM (17), which is very close to the K m value of choline uptake in this study, in contrast to those for CHT1 (K m = 0.5 -2 μM) and the OCT family of transporters (K m = 100 -450 μM). The kinetics data indicate that choline transport in keratinocytes does not occur via CHT1 or the OCT family.
CHT1 is a high-affinity choline transporter that has been reported to be found in cholinergic neuronal membranes; it is Na + -dependent and can be blocked by HC-3 at a very low concentration (K i = 50 -100 nM). Recently, CHT1 immunoreactivity has been identified in human keratinocytes and HaCaT cells (9) and in ciliated cells of the tracheal epithelium (7) by immunohistochemistry. These authors suggested that CHT1 is a novel component of the intrinsic non-neuronal cholinergic system of the skin. However, functional studies have shown that immortalized human keratinocyte HaCaT cells express a high-affinity Na + -independent choline transporter (22) . We found that CHT1 mRNA was not expressed in human keratinocytes. In addition, the K i value of HC-3 (K i = 16.5 μM) is much higher than the values in the literature, and [
3 H]choline uptake was also observed under Na + -free conditions. These findings strongly suggest that CHT1 plays no role in the uptake of choline by human keratinocytes.
As an organic cation, choline is a substrate for the OCT family. To date, three different electrogenic organic cation transporters have been cloned and characterized with regard to functionally (23) . These transporters, known as OCT1, OCT2, and OCT3, exhibit a broad and overlapping substrate-specificity toward organic cations (12 -14) . OCT1 and OCT2 accept choline as a substrate with comparatively low affinity. The transport process is Na + -independent, and the K t values for OCT1 and OCT2 are 620 and 210 μM, respectively. However, OCT3 does not recognize choline as a substrate (12, 14) . Therefore, we examined whether choline uptake into human keratinocytes is mediated by OCTs. In the present study, there is very little expression of OCT1-3 mRNAs compared with the expression of CTL1 mRNA. The choline transport system in keratinocytes resembles OCTs with regard to some pharmacological and functional properties such as sensitivity of the organic cation compound, Na + -independence, and potential-sensitive. However, TEA, a prototypical OCT substrate, did not cause any inhibition at up to 1 mM. TEA is very often used as a high-affinity reference compound for OCTs and has K i values of 46.6 and 52.2 μM for OCT1 and OCT2, respectively (24) . These biochemical and pharmacological data show that choline uptake in keratinocytes does not occur via OCTs. RT-PCR analysis of the expression of CTL1 and its splice variants (CTL1a, CTL1b, and CTL1c) in human keratinocytes. The reactions using specific primers were performed as described in Table 1 . PCR products were separated by electrophoresis on 2% agarose gels and detected with ethidium bromide to visualize bands. M corresponds to a 100-bp DNA ladder.
3 H]choline uptake in keratinocytes. [ 3 H]Choline uptake in keratinocytes was markedly reduced when the keratinocyte membrane potential was depolarized by increasing the concentration of K + in the uptake buffer. These findings support the notion of electrogenicallyfacilitated transport of choline in keratinocytes. Due to its positive charge at physiological pH, the rate of choline movement across cell membranes would be expected to be affected by changes in the membrane potential.
Next, we searched for a new transporter that could be part of a Na + -independent choline transport system. Recently, a novel family of choline transporters, called choline transporter-like protein 1 (CTL1), has been cloned from Torpedo marmorata (15, 17) . Rat CTL1 was also cloned as a homologous rat gene of the CTL protein family and exhibited saturable, high concentration of HC-3-inhibitable (K i value >10 μM), and weak Na + -dependent uptake of choline (16, 17, 25) . Recently, three major human splice variants of CTL1 (CTL1a, CTL1b, and CTL1c) were identified. However, the expression pattern and transporter function of these splice variants are not well known. We examined whether the CTL1 mediates choline uptake in human keratinocytes. In the present study, human keratinocytes expressed mRNA for CTL1, mainly the CTL1a subtype. Furthermore, kinetics data indicated that the K m value of [
3 H]choline uptake in keratinocytes was very close to the K m value for CTL1. The Eadie-Hofstee plot shows a single straight line, suggesting that choline uptake is mediated by a single transport system. Together, these results suggest that CTL1a is functionally expressed in keratinocytes and is responsible for choline uptake in these cells.
In conclusion, the functional expression of the Na + -independent choline transporter CTL1, mainly the CTL1a subtype, by human keratinocytes is responsible for the uptake of choline and organic cations. Previous reports demonstrated that keratinocytes express specific receptors for ACh and that kerationocyte-derived ACh can affect physiological cell functions by an autocrine / paracrine system. Furthermore, changes in ACh metabolism have been found in skin lesions of various dermatologic patients (20, 26, 27) . It is conceivable that perturbations of the keratinocyte choline transport system may be involved in skin diseases, and drugs that influence this system may be useful in treating them.
